Authors: Winski, SL Swann, E Hargreaves, RHJ Dehn, DL Butler, J Moody, CJ Ross, D

Citation: Sl. Winski et al., Relationship between NAD(P)H : quinone oxidoreductase 1 (NQO1) levels in aseries of stably transfected cell lines and susceptibility to antitumor quinones, BIOCH PHARM, 61(12), 2001, pp. 1509-1516

Authors: Hargreaves, RHJ Hartley, JA Butler, J

Citation: Rhj. Hargreaves et al., Mechanisms of action of quinone-containing alkylating agents: DNA alkylation by aziridinylquinones, FRONT BIOSC, 5, 2000, pp. E172-E180

Authors: Di Francesco, AM Hargreaves, RHJ Wallace, TW Mayalarp, SP Hazratis, A Hartley, JA Butler, J

Citation: Am. Di Francesco et al., The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters, ANTI-CAN DR, 15(5), 2000, pp. 347-359

Authors: Khan, P Abbas, S Hargreaves, RHJ Caffrey, R Megram, V McGown, A

Citation: P. Khan et al., Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatographic assay for the novel bio-reductive anti-tumor agent RH1 in human and mouse plasma, J CHROMAT B, 729(1-2), 1999, pp. 287-295

Authors: Hargreaves, RHJ O'Hare, CC Hartley, JA Ross, D Butler, J

Citation: Rhj. Hargreaves et al., Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents, J MED CHEM, 42(12), 1999, pp. 2245-2250

Authors: Winski, SL Hargreaves, RHJ Butler, J Ross, D

Citation: Sl. Winski et al., A new screening system for NAD(P)H : quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent, CLIN CANC R, 4(12), 1998, pp. 3083-3088